BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18565217)

  • 1. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial.
    van Mello NM; Mol F; Adriaanse AH; Boss EA; Dijkman AB; Doornbos JP; Emanuel MH; Friederich J; Leeuw-Harmsen Lv; Lips JP; van Santbrink EJ; Verhoeve HR; Visser H; Ankum WM; Veen Fv; Mol BW; Hajenius PJ
    BMC Womens Health; 2008 Jun; 8():10. PubMed ID: 18565217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
    van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
    Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.
    Casikar I; Lu C; Reid S; Bignardi T; Mongelli M; Morris A; Wild R; Condous G
    Rev Recent Clin Trials; 2012 Aug; 7(3):238-43. PubMed ID: 22540910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
    Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
    Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.
    Mol F; Mol BW; Ankum WM; van der Veen F; Hajenius PJ
    Hum Reprod Update; 2008; 14(4):309-19. PubMed ID: 18522946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic accuracy of a novel methotrexate protocol for the resolution of tubal ectopic pregnancies.
    Leonardi M; Allison E; Lu C; Nadim B; Condous G
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():186-190. PubMed ID: 32126410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.
    Jurkovic D; Memtsa M; Sawyer E; Donaldson AN; Jamil A; Schramm K; Sana Y; Otify M; Farahani L; Nunes N; Ambler G; Ross JA
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):171-176. PubMed ID: 27731538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial.
    Silva PM; Araujo Júnior E; Cecchino GN; Elito Júnior J; Camano L
    Arch Gynecol Obstet; 2015 Apr; 291(4):939-43. PubMed ID: 25315383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of health-related quality of life in women with ectopic pregnancy or pregnancy of unknown location treated with systemic methotrexate or expectant management.
    van Mello NM; Mol F; Hajenius PJ; Ankum WM; Mol BW; van der Veen F; van Wely M
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():1-5. PubMed ID: 26125101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of tubal ectopic pregnancy.
    van Mello NM; Mol F; Mol BW; Hajenius PJ
    Best Pract Res Clin Obstet Gynaecol; 2009 Aug; 23(4):509-18. PubMed ID: 19299204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy.
    Sowter MC; Farquhar CM; Petrie KJ; Gudex G
    BJOG; 2001 Feb; 108(2):192-203. PubMed ID: 11236120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol.
    May J; Duncan C; Mol B; Bhattacharya S; Daniels J; Middleton L; Hewitt C; Coomarasamy A; Jurkovic D; Bourne T; Bottomley C; Peace-Gadsby A; Doust A; Tong S; Horne AW
    Trials; 2018 Nov; 19(1):643. PubMed ID: 30458863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for non-tubal ectopic pregnancy.
    Long Y; Zhu H; Hu Y; Shen L; Fu J; Huang W
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD011174. PubMed ID: 32609376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of pregnancies of unknown location according to four different hCG-based protocols.
    Fistouris J; Bergh C; Strandell A
    Hum Reprod; 2016 Oct; 31(10):2203-11. PubMed ID: 27580995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictors of successful methotrexate treatment of tubal ectopic pregnancy.
    Abdelfattah-Arafa E; Abdussalam HF; Omar Saad M; El Ansari W
    J Obstet Gynaecol; 2024 Dec; 44(1):2361456. PubMed ID: 38864434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies.
    Nazac A; Gervaise A; Bouyer J; de Tayrac R; Capella-Allouc S; Fernandez H
    Ultrasound Obstet Gynecol; 2003 Feb; 21(2):181-5. PubMed ID: 12601843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
    Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy.
    Kazandi M; Turan V
    Clin Exp Obstet Gynecol; 2011; 38(1):67-70. PubMed ID: 21485731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?
    Akdaş Reis Y; Akay A; Özkan M; Fıratlıgil FB; Dereli ML; Kınay T; Erkaya S
    Arch Gynecol Obstet; 2024 Jun; 309(6):2585-2590. PubMed ID: 37493778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
    Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
    Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.